Gainers
- Nanobiotix NBTX shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.
- Avrobio AVRO stock increased by 9.83% to $1.0. The market value of their outstanding shares is at $43.6 million.
- Biodesix BDSX stock moved upwards by 9.26% to $2.24. The company's market cap stands at $89.3 million.
- Axcella Health AXLA shares rose 9.23% to $2.01. The market value of their outstanding shares is at $105.6 million.
- Cabaletta Bio CABA stock rose 7.62% to $1.27. The market value of their outstanding shares is at $36.8 million.
- SIGA Technologies SIGA stock rose 6.45% to $18.3. SIGA Technologies's trading volume hit 2.7 million shares by close, accounting for 20.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion.
Losers
- ThermoGenesis Holdings THMO shares fell 14.6% to $0.23 during Friday's after-market session. Today's trading volume for this security ended up closing at 10.3 million shares, which is 515.5 percent of its average volume over the last 100 days. The company's market cap stands at $7.2 million.
- Reviva Pharmaceuticals RVPH stock decreased by 7.22% to $0.59. Trading volume for this security closed at 1.4 million, accounting for 1912.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.9 million.
- BeyondSpring BYSI shares declined by 6.48% to $1.3. The market value of their outstanding shares is at $50.6 million.
- Nuwellis NUWE shares decreased by 5.82% to $0.53. The market value of their outstanding shares is at $5.5 million.
- Revelation Biosciences REVBU stock declined by 5.69% to $0.83. This security traded at a volume of 368.0K shares come close, making up 81.9% of its average volume over the last 100 days.
- Cue Health HLTH shares fell 5.03% to $3.21. The market value of their outstanding shares is at $473.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in